Page last updated: 2024-08-24

remifentanil and Pantothenate Kinase-Associated Neurodegeneration

remifentanil has been researched along with Pantothenate Kinase-Associated Neurodegeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carrero, E; Fàbregas, N; Hurtado, P; Rumia, J; Salvador, L1

Other Studies

1 other study(ies) available for remifentanil and Pantothenate Kinase-Associated Neurodegeneration

ArticleYear
[Anesthesia considerations for deep-brain stimulation in a patient with type-2 pantothenate kinase deficiency (Hallervorden-Spatz disease)].
    Revista espanola de anestesiologia y reanimacion, 2009, Volume: 56, Issue:3

    Topics: Adult; Androstanols; Anesthesia, Intravenous; Deep Brain Stimulation; Dystonic Disorders; Female; Globus Pallidus; Humans; Intubation, Intratracheal; Muscle Rigidity; Neuromuscular Nondepolarizing Agents; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Piperidines; Preanesthetic Medication; Propofol; Radiography, Interventional; Remifentanil; Rocuronium

2009